50
Participants
Start Date
August 31, 2025
Primary Completion Date
December 1, 2025
Study Completion Date
December 1, 2025
THC
Participants will receive THC into a rapidly flowing IV infusion.
Placebo
Participants will receive an equivalent amount (about 1-2 ml) of placebo (sterile 190 proof USP ethanol). The placebo does not produce any measurable blood alcohol levels or subjective/behavioral effects.
VA Connecticut Healthcare System, Yale School of Medicine, West Haven
National Institute on Drug Abuse (NIDA)
NIH
Yale University
OTHER